The amount of input target protein sample to use depends on the detection limit of the assay, but 10% of the amount added to each binding reaction (3 μl) is usually sufficient. The unbound target ...

A pure sample of protein is required to generate antibodies, conduct binding assays and study structure. Yet the target protein must first be isolated; the debris, salts and reagents washed away ...

This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and ...

The global luciferase assay market is set to experience robust growth, with its valuation projected to rise from USD 1,536.70 million in 2024 to USD 3,022.90 million by 2034, registering a CAGR of ...

Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.

In a first, scientists have identified promising drug candidates that can permanently disable a key cancer protein once deemed untreatable—a discovery that could revolutionize cancer treatment. Using ...

A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from patients with certain neurodegenerative diseases. This has the potential to ...

For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

The Zika virus builds tiny tunnels, called tunneling nanotubes, to stealthily transport material needed to infect nearby ...

Breast cancer is one of the leading causes of mortality among women worldwide. Tumor necrosis factor α-induced protein 3-interacting protein 1 (TNIP1) is a ubiquitin-binding protein that is widely ...